Therapeutic Potential of Dental Pulp Stem Cell Secretome for Alzheimer's Disease Treatment: An In Vitro Study

The secretome obtained from stem cell cultures contains an array of neurotrophic factors and cytokines thatmight have the potential to treat neurodegenerative conditions. Alzheimer’s disease (AD) is one of the most common human late onset and sporadic neurodegenerative disorders. Here, we investigated the therapeutic potential of secretome derived from dental pulp stem cells (DPSCs) to reduce cytotoxicity and apoptosis caused by amyloid beta (Aβ) peptide. We determined whether DPSCs can secrete the Aβ-degrading enzyme, neprilysin (NEP), and evaluated the effects of NEP expression in vitro by quantitating Aβ-degrading activity.The results showed that DPSC secretome contains higher concentrations of VEGF, Fractalkine, RANTES,MCP-1, andGMCSF compared to those of bone marrow and adipose stem cells. Moreover, treatment with DPSC secretome significantly decreased the cytotoxicity of Aβ peptide by increasing cell viability compared to nontreated cells. In addition, DPSC secretome stimulated the endogenous survival factor Bcl-2 and decreased the apoptotic regulator Bax. Furthermore, neprilysin enzyme was detected in DPSC secretome and succeeded in degrading Aβ 1–42 in vitro in 12 hours. In conclusion, our study demonstrates that DPSCs may serve as a promising source for secretome-based treatment of Alzheimer’s disease.

[1]  A. Salgado,et al.  Secretome of Mesenchymal Progenitors from the Umbilical Cord Acts as Modulator of Neural/Glial Proliferation and Differentiation , 2014, Stem Cell Reviews and Reports.

[2]  Claire Paquet,et al.  Neuroinflammation and Aβ Accumulation Linked To Systemic Inflammation Are Decreased By Genetic PKR Down-Regulation , 2015, Scientific Reports.

[3]  M. Berry,et al.  Paracrine-Mediated Neuroprotection and Neuritogenesis of Axotomised Retinal Ganglion Cells by Human Dental Pulp Stem Cells: Comparison with Human Bone Marrow and Adipose-Derived Mesenchymal Stem Cells , 2014, PloS one.

[4]  S. Ikehara,et al.  Stem Cell Treatment for Alzheimer’s Disease , 2014, International journal of molecular sciences.

[5]  D. Xue,et al.  Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease. , 2014, Free radical biology & medicine.

[6]  H. Park,et al.  Mesenchymal stem cells enhance autophagy and increase β-amyloid clearance in Alzheimer disease models , 2014, Autophagy.

[7]  S. V. Anisimov,et al.  The secretome of mesenchymal stem cells: potential implications for neuroregeneration. , 2013, Biochimie.

[8]  B. Winblad,et al.  VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival , 2013, Scientific Reports.

[9]  J. Richardson,et al.  Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease. , 2013, Current Alzheimer research.

[10]  K. Takagaki,et al.  Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes , 2013, Scientific Reports.

[11]  Y. Gong,et al.  Intracerebral Transplantation of Adipose-Derived Mesenchymal Stem Cells Alternatively Activates Microglia and Ameliorates Neuropathological Deficits in Alzheimer's Disease Mice , 2013, Cell transplantation.

[12]  W. Han,et al.  STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells , 2012, Molecular Cancer Research.

[13]  G. Camussi,et al.  Therapeutic potential of mesenchymal stem cell-derived microvesicles. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  Joong-Kook Choi,et al.  FGF-2 inhibits TNF-α mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells. , 2012, BMB reports.

[15]  M. Ueda,et al.  Human dental pulp-derived stem cells promote locomotor recovery after complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. , 2011, The Journal of clinical investigation.

[16]  I. Kerkis,et al.  Human dental pulp cells: a new source of cell therapy in a mouse model of compressive spinal cord injury. , 2011, Journal of neurotrauma.

[17]  G. Duruksu,et al.  Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells , 2011, Histochemistry and Cell Biology.

[18]  R. Ransohoff,et al.  CX3CR1 Protein Signaling Modulates Microglial Activation and Protects against Plaque-independent Cognitive Deficits in a Mouse Model of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[19]  M. Freedman,et al.  Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases , 2011, The Lancet Neurology.

[20]  R. Prediger,et al.  Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β1–40 administration in mice: Evidence for dissociation between cognitive deficits and neuronal damage , 2010, Experimental Neurology.

[21]  P. Calabresi,et al.  FLT-3 expression and function on microglia in multiple sclerosis. , 2010, Experimental and molecular pathology.

[22]  D. Dickson,et al.  Expression and functional profiling of neprilysin, insulin‐degrading enzyme, and endothelin‐converting enzyme in prospectively studied elderly and Alzheimer’s brain , 2010, Journal of neurochemistry.

[23]  M. Morganti-Kossmann,et al.  Role of CCL2 (MCP-1) in Traumatic Brain Injury (TBI): Evidence from Severe TBI Patients and CCL2−/− Mice , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  P. Grammas,et al.  RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role , 2010, Neurobiology of Aging.

[25]  N. Relkin,et al.  Natural human antibodies to amyloid beta peptide. , 2008, Autoimmunity reviews.

[26]  I. Kerkis,et al.  Isolation and Characterization of a Population of Immature Dental Pulp Stem Cells Expressing OCT-4 and Other Embryonic Stem Cell Markers , 2007, Cells Tissues Organs.

[27]  Mark P Mattson,et al.  Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. , 2006, Antioxidants & redox signaling.

[28]  A. Asawachaicharn,et al.  Human mesenchymal stem cell subpopulations express a variety of neuro-regulatory molecules and promote neuronal cell survival and neuritogenesis , 2006, Experimental Neurology.

[29]  N. Gavaldà,et al.  Brain‐derived neurotrophic factor prevents changes in Bcl‐2 family members and caspase‐3 activation induced by excitotoxicity in the striatum , 2005, Journal of neurochemistry.

[30]  L. Olson,et al.  Dental pulp cells provide neurotrophic support for dopaminergic neurons and differentiate into neurons in vitro; implications for tissue engineering and repair in the nervous system , 2004, The European journal of neuroscience.

[31]  E. Beierle,et al.  VEGF upregulates Bcl-2 expression and is associated with decreased apoptosis in neuroblastoma cells. , 2002, Journal of pediatric surgery.

[32]  K. Bacon,et al.  The Chemokine Fractalkine Inhibits Fas-Mediated Cell Death of Brain Microglia , 2000, Journal of Immunology.

[33]  R E Burke,et al.  Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.

[34]  B. Yankner.  Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[35]  J. Padmanabhan,et al.  GM-CSF upregulated in rheumatoid arthritis reverses cognitive impairment and amyloidosis in Alzheimer mice. , 2010, Journal of Alzheimer's disease : JAD.

[36]  O. Forlenza,et al.  The neuroprotective effect of dental pulp cells in models of Alzheimer’s and Parkinson’s disease , 2008, Journal of Neural Transmission.